Age-Adjusted Schedules of Venetoclax and Hypomethylating Agents to Treat Extremely Elderly Patients with Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is associated with particularly poor outcomes in the elderly population, in whom the disease is most prevalent. BCL-2 has been identified as an antiapoptotic protein and promotes survival of leukemia stem cells. Recently, the United States FDA has approved venetoclax, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Aaron M., Goodman, Aaron M., Mangan, James K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9064535/
https://www.ncbi.nlm.nih.gov/pubmed/35515507
http://dx.doi.org/10.1155/2022/2802680

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9064535/
https://www.ncbi.nlm.nih.gov/pubmed/35515507
http://dx.doi.org/10.1155/2022/2802680

Ejemplares similares